Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Aug;64(2):205–207. doi: 10.1038/bjc.1991.276

Can we prevent breast cancer?

M Baum, Y Ziv, A A Colletta
PMCID: PMC1977542  PMID: 1892745

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyd N. F., Cousins M., Lockwood G., Tritchler D. The feasibility of testing experimentally the dietary fat-breast cancer hypothesis. Br J Cancer. 1990 Dec;62(6):878–881. doi: 10.1038/bjc.1990.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bruning P. F., Bonfrer J. M., Hart A. A., de Jong-Bakker M., Linders D., van Loon J., Nooyen W. J. Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer. 1988 Oct;58(4):497–499. doi: 10.1038/bjc.1988.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Caleffi M., Fentiman I. S., Clark G. M., Wang D. Y., Needham J., Clark K., La Ville A., Lewis B. Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain. J Endocrinol. 1988 Nov;119(2):335–339. doi: 10.1677/joe.0.1190335. [DOI] [PubMed] [Google Scholar]
  4. Coles C., Thompson A. M., Elder P. A., Cohen B. B., Mackenzie I. M., Cranston G., Chetty U., Mackay J., Macdonald M., Nakamura Y. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet. 1990 Sep 29;336(8718):761–763. doi: 10.1016/0140-6736(90)93236-i. [DOI] [PubMed] [Google Scholar]
  5. Colletta A. A., Howell F. V., Baum M. A novel binding site for a synthetic progestagen in breast cancer cells. J Steroid Biochem. 1989 Dec;33(6):1055–1061. doi: 10.1016/0022-4731(89)90409-3. [DOI] [PubMed] [Google Scholar]
  6. Cuzick J., Wang D. Y., Bulbrook R. D. The prevention of breast cancer. Lancet. 1986 Jan 11;1(8472):83–86. doi: 10.1016/s0140-6736(86)90729-4. [DOI] [PubMed] [Google Scholar]
  7. Dupont W. D., Page D. L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146–151. doi: 10.1056/NEJM198501173120303. [DOI] [PubMed] [Google Scholar]
  8. Fentiman I. S., Caleffi M., Rodin A., Murby B., Fogelman I. Bone mineral content of women receiving tamoxifen for mastalgia. Br J Cancer. 1989 Aug;60(2):262–264. doi: 10.1038/bjc.1989.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fornander T., Rutqvist L. E., Cedermark B., Glas U., Mattsson A., Silfverswärd C., Skoog L., Somell A., Theve T., Wilking N. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 1989 Jan 21;1(8630):117–120. doi: 10.1016/s0140-6736(89)91141-0. [DOI] [PubMed] [Google Scholar]
  10. Gotfredsen A., Christiansen C., Palshof T. The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer. Cancer. 1984 Feb 15;53(4):853–857. doi: 10.1002/1097-0142(19840215)53:4<853::aid-cncr2820530406>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  11. Gottardis M. M., Jordan V. C. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res. 1987 Aug 1;47(15):4020–4024. [PubMed] [Google Scholar]
  12. Hardell L. Tamoxifen as risk factor for carcinoma of corpus uteri. Lancet. 1988 Sep 3;2(8610):563–563. doi: 10.1016/s0140-6736(88)92675-x. [DOI] [PubMed] [Google Scholar]
  13. Jordan V. C. Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations. Cancer Invest. 1988;6(5):589–595. doi: 10.3109/07357908809082124. [DOI] [PubMed] [Google Scholar]
  14. Love R. R., Mazess R. B., Tormey D. C., Barden H. S., Newcomb P. A., Jordan V. C. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat. 1988 Dec;12(3):297–302. doi: 10.1007/BF01811242. [DOI] [PubMed] [Google Scholar]
  15. Love R. R. Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. J Clin Oncol. 1989 Jun;7(6):803–815. doi: 10.1200/JCO.1989.7.6.803. [DOI] [PubMed] [Google Scholar]
  16. Mills P. K., Annegers J. F., Phillips R. L. Animal product consumption and subsequent fatal breast cancer risk among Seventh-day Adventists. Am J Epidemiol. 1988 Mar;127(3):440–453. doi: 10.1093/oxfordjournals.aje.a114821. [DOI] [PubMed] [Google Scholar]
  17. Powles T. J., Hardy J. R., Ashley S. E., Farrington G. M., Cosgrove D., Davey J. B., Dowsett M., McKinna J. A., Nash A. G., Sinnett H. D. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer. 1989 Jul;60(1):126–131. doi: 10.1038/bjc.1989.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Powles T. J., Tillyer C. R., Jones A. L., Ashley S. E., Treleaven J., Davey J. B., McKinna J. A. Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. Eur J Cancer. 1990;26(6):680–684. doi: 10.1016/0277-5379(90)90116-b. [DOI] [PubMed] [Google Scholar]
  19. Prentice R. L., Kakar F., Hursting S., Sheppard L., Klein R., Kushi L. H. Aspects of the rationale for the Women's Health Trial. J Natl Cancer Inst. 1988 Aug 3;80(11):802–814. doi: 10.1093/jnci/80.11.802. [DOI] [PubMed] [Google Scholar]
  20. Ratko T. A., Detrisac C. J., Dinger N. M., Thomas C. F., Kelloff G. J., Moon R. C. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res. 1989 Aug 15;49(16):4472–4476. [PubMed] [Google Scholar]
  21. Rössner S., Wallgren A. Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis. 1984 Sep;52(3):339–346. doi: 10.1016/0021-9150(84)90064-9. [DOI] [PubMed] [Google Scholar]
  22. Tormey D. C. Tamoxifen: transition from the laboratory to clinical preventive chemosuppression. Cancer Invest. 1988;6(5):597–600. doi: 10.3109/07357908809082125. [DOI] [PubMed] [Google Scholar]
  23. Turken S., Siris E., Seldin D., Flaster E., Hyman G., Lindsay R. Effects of tamoxifen on spinal bone density in women with breast cancer. J Natl Cancer Inst. 1989 Jul 19;81(14):1086–1088. doi: 10.1093/jnci/81.14.1086. [DOI] [PubMed] [Google Scholar]
  24. Wile A. G., DiSaia P. J. Hormones and breast cancer. Am J Surg. 1989 Apr;157(4):438–442. doi: 10.1016/0002-9610(89)90596-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES